Tetraphase Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
TTPH
CUSIP
88165N105
All holders as of
Q2 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q2 1 1.00 $0
2025 Q1 1 1.00 $0
2024 Q4 1 1.00 $0
2024 Q3 1 1.00 $0
2024 Q2 1 1.00 $0
2024 Q1 1 1.00 $0
2023 Q4 1 1.00 $0
2023 Q3 1 1.00 $0
2023 Q2 1 1.00 $0
2023 Q1 1 1.00 $0
2022 Q4 1 1.00 $0
2022 Q3 1 1.00 $0
2022 Q2 1 1.00 $0
2022 Q1 1 1.00 $0
2021 Q4 1 1.00 $0
2021 Q3 1 1.00 $0
2021 Q2 1 1.00 $0
2021 Q1 1 1.00 $0
2020 Q4 1 1.00 $0
2020 Q3 1 1.00 $0
2020 Q2 1 1.00 $0
2020 Q1 2 1.00 $0
2019 Q4 2 1.00 $0
2019 Q3 2 1.00 $0
2019 Q2 71 17.2 M $8.24 M
2019 Q1 80 21.0 M $28.1 M
2018 Q4 91 24.2 M $27.4 M
2018 Q3 101 23.6 M $65.1 M
2018 Q2 94 21.8 M $77.9 M
2018 Q1 101 23.5 M $72.1 M
2017 Q4 109 30.3 M $191 M
2017 Q3 100 29.9 M $204 M
2017 Q2 96 21.3 M $152 M
2017 Q1 94 18.8 M $173 M
2016 Q4 97 18.2 M $73.2 M
2016 Q3 94 20.2 M $77.4 M
2016 Q2 95 21.8 M $93.8 M
2016 Q1 108 23.5 M $109 M
2015 Q4 113 26.7 M $268 M
2015 Q3 123 28.3 M $212 M
2015 Q2 144 27.5 M $1.30 B
2015 Q1 138 25.6 M $937 M
2014 Q4 100 20.9 M $831 M
2014 Q3 77 14.3 M $286 M
2014 Q2 72 16.5 M $215 M
2014 Q1 67 13.9 M $150 M